Related Experiment Video
Updated: Mar 20, 2026
Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage
Published on: July 3, 2014
Genetic Determinants of Risk, Severity, and Outcome in Intracerebral Hemorrhage
Guido J Falcone1, Jonathan Rosand1
1Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts.
Insights
Genetic research into intracerebral hemorrhage (ICH), a severe stroke type, is crucial for finding new treatments. Recent discoveries and a new platform aim to accelerate genetic insights into cerebrovascular disease.
Area of Science:
- Neurology
- Genetics
- Cerebrovascular Disease Research
Background:
- Spontaneous, nontraumatic intracerebral hemorrhage (ICH) is a severe complication of cerebral small vessel disease.
- ICH accounts for a significant portion of stroke-related mortality and healthcare costs, despite representing 15% of all strokes.
- Current preventive and acute treatments for ICH are limited.
Purpose of the Study:
- To summarize recent genetic discoveries related to intracerebral hemorrhage.
- To introduce the Platform for Accelerating Genetic Discovery for Cerebrovascular Disease.
- To highlight the potential of genomic analyses in identifying novel biological mechanisms and therapeutic targets for ICH.
Main Methods:
- Review of recent genetic discoveries in intracerebral hemorrhage.
- Introduction of a new collaborative resource, the Platform for Accelerating Genetic Discovery for Cerebrovascular Disease.
- Description of the platform's goal to aggregate data from 100,000 stroke cases and controls.
Main Results:
- Recent genetic discoveries have identified key biological mechanisms contributing to ICH.
- The newly established platform provides a centralized workspace for large-scale genetic analyses.
- The initiative aims to significantly increase the power of genetic studies in cerebrovascular disease.
Conclusions:
- Genetic variation plays a substantial role in the occurrence of ICH.
- Genomic analyses are essential for uncovering new therapeutic targets.
- The Platform for Accelerating Genetic Discovery for Cerebrovascular Disease is a key resource for advancing ICH research and developing innovative treatments.
Abstract:
Spontaneous, nontraumatic intracerebral hemorrhage (ICH) is the most severe manifestation of common forms of cerebral small vessel disease. Although ICH represents only 15% of all strokes, it accounts for a large proportion of stroke-related costs and mortality. Preventive and acute treatments remain limited. Because genetic variation contributes substantially to ICH, genomic analyses constitute a powerful tool to identify new biological mechanisms involved in its occurrence. Through translational research efforts, these newly identified mechanisms can become targets for innovative therapeutic interventions. Here, the authors summarize the most recent genetic discoveries for ICH. They also introduce the Platform for Accelerating Genetic Discovery for Cerebrovascular Disease, a newly created resource that aims to create a common workspace for genetic analyses that will bring together 100,000 stroke cases and suitable controls from numerous institutions in several countries.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
01:28Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
01:11Genetic Lingo
01:29Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...